These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23110818)

  • 1. Thermodynamic and structural destabilization of apoE3 by hereditary mutations associated with the development of lipoprotein glomerulopathy.
    Georgiadou D; Stamatakis K; Efthimiadou EK; Kordas G; Gantz D; Chroni A; Stratikos E
    J Lipid Res; 2013 Jan; 54(1):164-76. PubMed ID: 23110818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic destabilization and aggregation propensity as the mechanism behind the association of apoE3 mutants and lipoprotein glomerulopathy.
    Katsarou M; Stratikos E; Chroni A
    J Lipid Res; 2018 Dec; 59(12):2339-2348. PubMed ID: 30309894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy.
    Stratikos E; Chroni A
    Clin Exp Nephrol; 2014 Apr; 18(2):225-9. PubMed ID: 24149834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical analysis of apolipoprotein E3 variants linked with development of type III hyperlipoproteinemia.
    Georgiadou D; Chroni A; Vezeridis A; Zannis VI; Stratikos E
    PLoS One; 2011; 6(11):e27037. PubMed ID: 22069485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
    Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N
    J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
    Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
    J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy.
    Saito T; Ishigaki Y; Oikawa S; Yamamoto TT
    Trends Cardiovasc Med; 2002 Feb; 12(2):67-70. PubMed ID: 11852253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.
    Chetty PS; Mayne L; Lund-Katz S; Englander SW; Phillips MC
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):968-973. PubMed ID: 28096372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swapping the N- and C-terminal domains of human apolipoprotein E3 and AI reveals insights into their structure/activity relationship.
    Lek MT; Cruz S; Ibe NU; Beck WHJ; Bielicki JK; Weers PMM; Narayanaswami V
    PLoS One; 2017; 12(6):e0178346. PubMed ID: 28644829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for increased risk for late-onset Alzheimer disease due to the naturally occurring L28P mutation in apolipoprotein E4.
    Argyri L; Dafnis I; Theodossiou TA; Gantz D; Stratikos E; Chroni A
    J Biol Chem; 2014 May; 289(18):12931-45. PubMed ID: 24644280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4.
    Nguyen D; Dhanasekaran P; Nickel M; Nakatani R; Saito H; Phillips MC; Lund-Katz S
    Biochemistry; 2010 Dec; 49(51):10881-9. PubMed ID: 21114327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of the carboxyl-terminal helical segment to the self-association and lipoprotein preferences of human apolipoprotein E3 and E4 isoforms.
    Sakamoto T; Tanaka M; Vedhachalam C; Nickel M; Nguyen D; Dhanasekaran P; Phillips MC; Lund-Katz S; Saito H
    Biochemistry; 2008 Mar; 47(9):2968-77. PubMed ID: 18201068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical and biophysical characterization of recombinant rat apolipoprotein E: similarities to human apolipoprotein E3.
    Tran TN; Kim SH; Gallo C; Amaya M; Kyees J; Narayanaswami V
    Arch Biochem Biophys; 2013 Jan; 529(1):18-25. PubMed ID: 23103361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E-related glomerular disorders.
    Saito T; Matsunaga A; Fukunaga M; Nagahama K; Hara S; Muso E
    Kidney Int; 2020 Feb; 97(2):279-288. PubMed ID: 31874799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities.
    Ito K; Nakashima H; Watanabe M; Ishimura A; Miyahara Y; Abe Y; Yasuno T; Ifuku M; Sasatomi Y; Saito T
    Nephrol Dial Transplant; 2012 Oct; 27(10):3899-907. PubMed ID: 22863838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy.
    Zhang B; Liu ZH; Zeng CH; Zheng JM; Chen HP; Zhou H; Li LS
    Chin Med J (Engl); 2005 Apr; 118(7):555-60. PubMed ID: 15820086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
    Saito T; Matsunaga A
    J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
    [No Abstract]   [Full Text] [Related]  

  • 19. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
    Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
    J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
    Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
    Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.